{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:32:10Z","timestamp":1776580330332,"version":"3.51.2"},"reference-count":62,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rare bleeding disorders (RBDs), defined as hereditary coagulation factor deficits other than haemophilia, are characterized by a heterogenous clinical phenotype ranging from life-threatening bleeding to thrombosis. There are uncertainties concerning treatment intensity and levels needed to achieve haemostasis, and epidemiological data from Germany, Austria, and Switzerland (GTH region) are scarce.<\/jats:p><jats:p>We performed a narrative literature review, focusing on bleeding phenotype and thrombotic risk. Epidemiologic data, including adults and children, and general treatment approaches have been collected via an online survey among GTH haemophilia centres (all categories) and the general information service of the German national registry (Deutsches H\u00e4mophilieregister, DHR).<\/jats:p><jats:p>We provided an overview on RBDs, revealing that especially in FV, FVII, and FXI deficiencies, the correlation between factor levels and bleeding phenotype is poor. A thrombotic risk needs to be considered in FVII deficiency and afibrinogenaemia or dysfibrinogenaemia. The survey was completed by 34 centres from Germany, Austria, and Switzerland, and compared with 137 centres reporting data to the DHR. FVII deficiency was confirmed to be the most frequent, and FII deficiency was the rarest RBD in this region. For treatment, single factor concentrates were preferred over multifactor concentrates or plasma, and tranexamic acid was often part of the treatment. Approximately 30, 40, and &lt;10% of patients with severe FV, FVII, and FXI deficiency (defined as factor level &lt;10%), respectively, were receiving prophylactic treatment, suggesting an overall milder bleeding phenotype.<\/jats:p><jats:p>More detailed registry data could give insights into the treatment landscape of RBDs, considering the challenge of clinical trials in rare diseases.<\/jats:p>","DOI":"10.1055\/a-2681-4611","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:56:20Z","timestamp":1760568980000},"page":"378-389","source":"Crossref","is-referenced-by-count":1,"title":["Overview on Rare Congenital Bleeding Disorders and Epidemiological Data from the German Haemophilia Registry (DHR) and a Survey in Germany, Austria, and Switzerland"],"prefix":"10.1055","volume":"45","author":[{"given":"Katharina","family":"Holstein","sequence":"additional","affiliation":[{"name":"University Medical Center Schleswig-Holstein, Institute for Clinical Chemistry, Coagulation Centre, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Gutensohn","sequence":"additional","affiliation":[{"name":"Werlhof-Institut MVZ, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Sonja","family":"Alesci","sequence":"additional","affiliation":[{"name":"MVZ IMD GmbH, IMD Blood Coagulation Center Hochtaunus, Bad Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Krause","sequence":"additional","affiliation":[{"name":"DKD Helios Klinik Wiesbaden, Center for Internal Medicine, Haemostaseology, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Scholz","sequence":"additional","affiliation":[{"name":"MVZ Labor Dr. Reising-Ackermann und Kollegen, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Wermes","sequence":"additional","affiliation":[{"name":"H\u00e4moZentrum Dr. Wermes, Hildesheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Halimeh","sequence":"additional","affiliation":[{"name":"University Hospital Essen, Pediatric Haematology Oncology, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0029-1225757","article-title":"Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management","volume":"35","author":"F Peyvandi","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia","volume":"133","author":"M Menegatti","year":"2019","journal-title":"Blood"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0044-1800832","article-title":"Correlation between phenotype and coagulation factor activity level in rare bleeding disorders: a systematic review","volume":"51","author":"B Tavasoli","year":"2025","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"P M Mannucci","year":"2004","journal-title":"Blood"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"J L Saes","year":"2020","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"A Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2516.2006.01299.x","article-title":"Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review","volume":"12","author":"A Girolami","year":"2006","journal-title":"Haemophilia"},{"issue":"09","key":"ref9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/jcm9113408","article-title":"The German Hemophilia Registry: growing with its tasks","volume":"9","author":"H Duda","year":"2020","journal-title":"J Clin Med"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and fibrin in hemostasis and thrombosis","volume":"37","author":"S Kattula","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"P de Moerloose","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"A Casini","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"S 03","key":"ref15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/hae.14986","article-title":"Rare bleeding disorders: advances in management [in Dutch]","volume":"30","author":"A Casini","year":"2024","journal-title":"Haemophilia"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/bloodadvances.2023012186","article-title":"Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database","volume":"8","author":"S Mohsenian","year":"2024","journal-title":"Blood Adv"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13296","article-title":"Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders","volume":"103","author":"G Castaman","year":"2019","journal-title":"Eur J Haematol"},{"issue":"21","key":"ref18","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020010116","article-title":"How I treat dysfibrinogenemia","volume":"138","author":"A Casini","year":"2021","journal-title":"Blood"},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"R Palla","year":"2015","journal-title":"Blood"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/hae.13876","article-title":"Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future","volume":"26","author":"A Casini","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.rpth.2024.102460","article-title":"Rare inherited coagulation disorders: no longer orphan and neglected","volume":"8","author":"S Mohsenian","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"22","key":"ref22","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2020009472","article-title":"Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia","volume":"137","author":"A Casini","year":"2021","journal-title":"Blood"},{"issue":"03","key":"ref23","first-page":"e55940","article-title":"Isolated prothrombin deficiency: a case report of a rare coagulation disorder and review of literature","volume":"16","author":"P Bollineni","year":"2024","journal-title":"Cureus"},{"key":"ref24","volume-title":"Investigation of hemostasis","author":"M A Laffan","year":"2017"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10245332.2017.1359900","article-title":"Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed","volume":"23","author":"A Girolami","year":"2018","journal-title":"Hematology"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"A D Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2002-01-0290","article-title":"Factor V: a combination of Dr Jekyll and Mr Hyde","volume":"101","author":"K G Mann","year":"2003","journal-title":"Blood"},{"issue":"18","key":"ref28","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.3390\/ijms22189705","article-title":"High mutational heterogeneity, and new mutations in the human coagulation factor V gene. Future perspectives for factor V deficiency using recombinant and advanced therapies","volume":"22","author":"S Bernal","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jth.15274","article-title":"Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besan\u00e7on)","volume":"19","author":"E Castoldi","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"102330","DOI":"10.1016\/j.rpth.2024.102330","article-title":"Factor V variants in bleeding and thrombosis","volume":"8","author":"A K Mohapatra","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1111\/hae.13538","article-title":"Recombinant FVIIa therapy for heavy menstrual bleeding in patients with severe FV deficiency","volume":"24","author":"Z Kaya","year":"2018","journal-title":"Haemophilia"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"e13102","DOI":"10.1111\/petr.13102","article-title":"Management of intracranial hemorrhage in severe factor V deficiency and definitive treatment with liver transplantation","volume":"22","author":"A W DesPain","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3324\/haematol.2020.248542","article-title":"Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis","volume":"106","author":"F Bernardi","year":"2021","journal-title":"Haematologica"},{"issue":"20","key":"ref34","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"J L Saes","year":"2020","journal-title":"Blood Adv"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/jcm13010049","article-title":"Genotype-phenotype relationship among 785 unrelated white women with inherited congenital factor VII deficiency: a three-center database study","volume":"13","author":"S Halimeh","year":"2023","journal-title":"J Clin Med"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/hae.14817","article-title":"Mild FVII deficiency\u2014correlation between genotype and phenotype","volume":"29","author":"C Fraser","year":"2023","journal-title":"Haemophilia"},{"issue":"08","key":"ref37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1160\/TH17-02-0085","article-title":"F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study","volume":"117","author":"G Quintavalle","year":"2017","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1076029611436196","article-title":"Congenital FVII deficiency and pulmonary embolism: a critical appraisal of all reported cases","volume":"19","author":"A Girolami","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"S 01","key":"ref39","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.thromres.2012.08.273","article-title":"Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?","volume":"130","author":"M Giansily-Blaizot","year":"2012","journal-title":"Thromb Res"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/ejh.13941","article-title":"Management of rare inherited bleeding disorders: proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders","volume":"110","author":"M Trossaert","year":"2023","journal-title":"Eur J Haematol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"100833","DOI":"10.1016\/j.blre.2021.100833","article-title":"Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency","volume":"50","author":"F Peyvandi","year":"2021","journal-title":"Blood Rev"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2516.2006.01303.x","article-title":"Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene","volume":"12","author":"F H Herrmann","year":"2006","journal-title":"Haemophilia"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1055\/a-1704-0841","article-title":"Analysis of 180 genetic variants in a new interactive FX variant database reveals novel insights into FX deficiency","volume":"5","author":"V A Harris","year":"2021","journal-title":"TH Open"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/hae.14894","article-title":"Plasma-derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency","volume":"30","author":"M A Escobar","year":"2024","journal-title":"Haemophilia"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.hoc.2021.07.012","article-title":"Factor XI deficiency","volume":"35","author":"M D Lewandowska","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/hae.14687","article-title":"Global epidemiology of factor XI deficiency: a targeted review of the literature and foundation reports","volume":"29","author":"X Zhang","year":"2023","journal-title":"Haemophilia"},{"issue":"05","key":"ref47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/hae.15075","article-title":"Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: experience from a haemophilia treatment centre","volume":"30","author":"S J Wu","year":"2024","journal-title":"Haemophilia"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/hae.12678","article-title":"Factor XI-related thrombosis and the role of concentrate treatment in factor XI deficiency","volume":"21","author":"G N Pike","year":"2015","journal-title":"Haemophilia"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12457","article-title":"FXI concentrate use and risk of thrombosis","volume":"20","author":"P Bolton-Maggs","year":"2014","journal-title":"Haemophilia"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH10-05-0307","article-title":"Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis","volume":"105","author":"O Salomon","year":"2011","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref51","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"O Salomon","year":"2008","journal-title":"Blood"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1538-7836.2003.00195.x","article-title":"Inherited factor XI deficiency confers no protection against acute myocardial infarction","volume":"1","author":"O Salomon","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"L Muszbek","year":"2011","journal-title":"Physiol Rev"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"L Hsieh","year":"2008","journal-title":"Haemophilia"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0037-1604109","article-title":"Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders\u2014prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency","volume":"44","author":"S ER Alavi","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref57","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"M Menegatti","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBC.0000000000001326","article-title":"The role of factor XIII in patient blood management","volume":"35","author":"M \u017duni\u0107","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2019.07.014","article-title":"The use of prophylaxis in the treatment of rare bleeding disorders","volume":"196","author":"A Shapiro","year":"2020","journal-title":"Thromb Res"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1055\/s-0039-1696685","article-title":"Single low dose of rFVIIa combined with antifibrinolytic agent is a simple and safe treatment for factor XI-deficient patients undergoing surgery","volume":"119","author":"O Salomon","year":"2019","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"102434","DOI":"10.1016\/j.rpth.2024.102434","article-title":"Exploring nonreplacement therapies' impact on hemophilia and other rare bleeding disorders","volume":"8","author":"F Peyvandi","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"102663","DOI":"10.1016\/j.bcmd.2022.102663","article-title":"Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study","volume":"95","author":"A A Barg","year":"2022","journal-title":"Blood Cells Mol Dis"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jth.15652","article-title":"Treatment of patients with rare bleeding disorders in the Netherlands: real-life data from the RBiN study","volume":"20","author":"D PMSM Maas","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/diagnostics11112140","article-title":"Congenital afibrinogenemia and hypofibrinogenemia: laboratory and genetic testing in rare bleeding disorders with life-threatening clinical manifestations and challenging management","volume":"11","author":"T Simurda","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2681-4611.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:56:26Z","timestamp":1760568986000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2681-4611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":62,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2681-4611","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}